SCP logo

Scope Fluidics S.A. Stock Price

WSE:SCP Community·zł440.4m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 5 Fair Values set on narratives written by author

SCP Share Price Performance

zł139.00
-53.60 (-27.83%)
zł139.00
-53.60 (-27.83%)
Price zł139.00

SCP Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with reasonable growth potential.

2 Risks
2 Rewards

Scope Fluidics S.A. Key Details

zł100.0k

Revenue

zł47.3m

Cost of Revenue

-zł47.2m

Gross Profit

-zł863.0k

Other Expenses

-zł46.4m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Apr 30, 2026
-14.63
-47,227.00%
-46,364.00%
0%
View Full Analysis

About SCP

Founded
2010
Employees
132
CEO
Piotr Garstecki
WebsiteView website
www.scopefluidics.com

Scope Fluidics S.A., a biotechnology company, designs and develops projects based on microfluidic technologies in medical diagnostics and healthcare in Poland. The company offers BacterOMIC, an antibiotic susceptibility testing. Scope Fluidics S.A. was founded in 2010 and is based in Warsaw, Poland.

Recent SCP News & Updates

Recent updates

No updates